Cancer

BioAffinity Technologies Nabs $15.6M from Public Offering

Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers

AnPac Bio Inks Deal for $3.7M Investment

Caris Life Sciences to Offer Molecular Profiling Services on Flatiron Health Platform

Liquid Biopsy Firm Hedera Dx Raises €14M in Seed Funding

Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection

Propath UK, Nucleai Partner on Spatial Proteomics Panel for Immuno-Oncology

Foundation Medicine, Day One Biopharmaceuticals to Develop CDx for Tovorafenib

Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests

Epigenomics Expecting Lower Loss in 2022 as It Launches Liquid Biopsy Study

BriaCell, Caris Life Sciences Partner to Bolster New Immunotherapy Development

AOA Dx Closes $7M Funding Round for Ovarian Cancer Test

SeekIn Nabs CE Mark for Cancer Assay

Foundation Medicine, Relay Therapeutics to Develop FoundationOne CDx for FGFR2 Inhibitor

Roche Obtains CE Mark for Ventana PD-L1 Assay as CDx for Libtayo

Becton Dickinson, Werfen, Viramed Biotech Gain 501(k) Clearances in August